Clal Biotechnology reported ILS16.49M in Cost of Sales for its fiscal quarter ending in June of 2022.





Cost Of Sales Change Date
aTyr Pharma USD 22.13M 6.75M Sep/2025
Clal Biotechnology ILS 16.49M 2.64M Jun/2022
Compugen USD 1.65M 10K Sep/2025
RedHill Biopharma USD 702K 0 Jun/2024